These data indicate that KLF9 overexpression augmented paclitaxel-induced activation of pro-caspase-3, whereas KLF9-knockdown attenuated or completely diminished paclitaxel apoptotic effects in RPMI-7951 or A375 malignant melanoma cell lines, respectively. Here, CASP3 is linked to melanoma.